This report presents a comprehensive overview, market shares, and growth opportunities of Nanotechnology in Drug Delivery market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Nanotechnology in Drug Delivery, covering the supply chain analysis, impact assessment to the Nanotechnology in Drug Delivery market size growth rate in several scenarios, and the measures to be undertaken by Nanotechnology in Drug Delivery companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Targeted Delivery
Drug Package
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Cancer
Tumor
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Access Pharmaceuticals
Alkermes
Camurus
Capsulution Pharma
Aquanova
Celgene
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nanotechnology in Drug Delivery market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nanotechnology in Drug Delivery market by identifying its various subsegments.
Focuses on the key global Nanotechnology in Drug Delivery players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanotechnology in Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Nanotechnology in Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanotechnology in Drug Delivery Market Size 2015-2025
2.1.2 Nanotechnology in Drug Delivery Market Size CAGR by Region
2.2 Nanotechnology in Drug Delivery Segment by Type
2.2.1 Targeted Delivery
2.2.2 Targeted Delivery
2.3 Nanotechnology in Drug Delivery Market Size by Type
2.3.1 Global Nanotechnology in Drug Delivery Market Size Market Share by Type (2015-2020)
2.3.2 Global Nanotechnology in Drug Delivery Market Size Growth Rate by Type (2015-2020)
2.4 Nanotechnology in Drug Delivery Segment by Application
2.4.1 Cancer
2.4.2 Tumor
2.4.3 Other
2.5 Nanotechnology in Drug Delivery Market Size by Application
2.5.1 Global Nanotechnology in Drug Delivery Market Size Market Share by Application (2015-2020)
2.5.2 Global Nanotechnology in Drug Delivery Market Size Growth Rate by Application (2015-2020)
3 Global Nanotechnology in Drug Delivery by Players
3.1 Global Nanotechnology in Drug Delivery Market Size Market Share by Players
3.1.1 Global Nanotechnology in Drug Delivery Market Size by Players (2018-2020)
3.1.2 Global Nanotechnology in Drug Delivery Market Size Market Share by Players (2018-2020)
3.2 Global Nanotechnology in Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanotechnology in Drug Delivery by Regions
4.1 Nanotechnology in Drug Delivery Market Size by Regions
4.2 Americas Nanotechnology in Drug Delivery Market Size Growth
4.3 APAC Nanotechnology in Drug Delivery Market Size Growth
4.4 Europe Nanotechnology in Drug Delivery Market Size Growth
4.5 Middle East & Africa Nanotechnology in Drug Delivery Market Size Growth
5 Americas
5.1 Americas Nanotechnology in Drug Delivery Market Size by Countries
5.2 Americas Nanotechnology in Drug Delivery Market Size by Type
5.3 Americas Nanotechnology in Drug Delivery Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nanotechnology in Drug Delivery Market Size by Regions
6.2 APAC Nanotechnology in Drug Delivery Market Size by Type
6.3 APAC Nanotechnology in Drug Delivery Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nanotechnology in Drug Delivery by Countries
7.2 Europe Nanotechnology in Drug Delivery Market Size by Type
7.3 Europe Nanotechnology in Drug Delivery Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nanotechnology in Drug Delivery by Countries
8.2 Middle East & Africa Nanotechnology in Drug Delivery Market Size by Type
8.3 Middle East & Africa Nanotechnology in Drug Delivery Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
..…..continued
CONTACT DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Market OverviewThe Global Nanotechnology in Drug Delivery Market is expected to grow at a high CAGR during the forecasting period (2020-2027).Nanotechnology in drug delivery is the rapidly developing way of providing effective treatment for various diseases.
Nanotechnology drug delivery utilizes the nanoscale range nanoparticles like liposomes, chemotherapeutic agents, biological agents, etc., to deliver the therapeutic agents to specifically targeted sites in a controlled manner.
The nanotechnology drug delivery has certain benefits including improving the ability to deliver poorly water-soluble drugs, reduce drug accumulation within healthy tissue, combine therapeutic and diagnostic modalities through one agent, transportation of drugs across epithelial and endothelial barriers, protection from the biological environment, effective treatment can be achieved by retaining the drug in the body long time.
For instance, on 5th Nov 2019, MIT engineers had been developed the nanoparticle coated with “right-handed” molecules orientation that had been offered to enhance drug delivery.Depending on technology type micelles, nanoparticles, liposomes, nanocrystals segments are also growing at a faster pace owing to increasing the demand for effective treatment drugs with the rising launching of new nano-based medicine.
For instance, on 14th May 2020, NanOlogy Company had been launched a new drug delivery injection Nanopac for targeting the treatment of Pancreatic Cancer and Mucinous Cystic Neoplasms.Depending on the applications, global nanotechnology in the drug delivery market is divided into anti-infective, neurology, anti-inflammatory/immunology, oncology, cardiovascular/physiology, and others.
For instance, Ventus launched Wednesday with $60 million from Versant Ventures and GV.
This report studies the global market size of Nanotechnologyin Drug Delivery in keyregions like North America, Europe, Asia Pacific, Central & South Americaand Middle East & Africa, focuses on the consumption of Nanotechnology inDrug Delivery inthese regions.
This report also studies the global market status, competitionlandscape, market share, growth rate, future trends, market drivers,opportunities and challenges, sales channels, distributors and Porter’s FiveForces Analysis.
Focuses on the key global Nanotechnology in Drug Delivery manufacturers, to define, describe and analyzethe sales volume, value, market share, market competition landscape, SWOTanalysis and development plans in next few years.
To strategically profile the key players and comprehensively analyze theirgrowth strategies.
Both top-down and bottom-up approaches have been used toestimate and validate the market size of Nanotechnology in Drug Delivery market, to estimate the size of various otherdependent submarkets in the overall market.
Key players in the market have beenidentified through secondary research, and their market shares have beendetermined through primary and secondary research.
